Preclinical News and Research

RSS
Researchers report increasing disparities between resource inputs, outcomes in biomedical research

Researchers report increasing disparities between resource inputs, outcomes in biomedical research

DelMar obtains additional funding to support ongoing research project with lead product candidate VAL-083

DelMar obtains additional funding to support ongoing research project with lead product candidate VAL-083

GlySens secures FDA approval to extend current human clinical evaluation of fully implanted CGM system

GlySens secures FDA approval to extend current human clinical evaluation of fully implanted CGM system

Bionik Laboratories reports net loss for second quarter 2015

Bionik Laboratories reports net loss for second quarter 2015

CMC Biologics, PATH Malaria Vaccine Initiative sign agreement for development of specific monoclonal antibodies

CMC Biologics, PATH Malaria Vaccine Initiative sign agreement for development of specific monoclonal antibodies

Ardelyx reports net income of $9.0 million for second quarter 2015

Ardelyx reports net income of $9.0 million for second quarter 2015

Next generation quantitative live-cell microscope released by Bruker

Next generation quantitative live-cell microscope released by Bruker

Endra photoacoustic CT preclinical imaging technology to be brought to Australia by AXT

Endra photoacoustic CT preclinical imaging technology to be brought to Australia by AXT

TNK Therapeutics acquires multiple preclinical and clinical stage CAR-T immunotherapy programs

TNK Therapeutics acquires multiple preclinical and clinical stage CAR-T immunotherapy programs

Lexicon Pharmaceuticals' revenues decrease to $0.4 million in second quarter 2015

Lexicon Pharmaceuticals' revenues decrease to $0.4 million in second quarter 2015

Heptares, AstraZeneca sign licensing agreement to develop and commercialise immuno-oncology treatments

Heptares, AstraZeneca sign licensing agreement to develop and commercialise immuno-oncology treatments

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

Pharmaxis, Synairgen partner to develop LOXL2 inhibitor to treat idiopathic pulmonary fibrosis

Pharmaxis, Synairgen partner to develop LOXL2 inhibitor to treat idiopathic pulmonary fibrosis

Imperial Innovations announces launch of pre-clinical spinout company, Orthonika

Imperial Innovations announces launch of pre-clinical spinout company, Orthonika

Prokarium receives funding to complete pre-clinical development of new Chlamydia vaccine

Prokarium receives funding to complete pre-clinical development of new Chlamydia vaccine

Scientists successfully test new tumor diagnosis method

Scientists successfully test new tumor diagnosis method

Combining chemotherapy and birinapant effective against high-grade serous ovarian cancer

Combining chemotherapy and birinapant effective against high-grade serous ovarian cancer

Shire acquires Foresight Biotherapeutics for $300 million

Shire acquires Foresight Biotherapeutics for $300 million

Research shows specific routes of administration can predict risk of drug addiction

Research shows specific routes of administration can predict risk of drug addiction

FDA accepts Mundipharma EDO's Investigational New Drug Application for EDO-S101

FDA accepts Mundipharma EDO's Investigational New Drug Application for EDO-S101

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.